Apolipoprotein E polymorphism and lipoprotein compositions in normolipidaemic xanthelasma patients

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 3, 2006, Pages 260-263

  Tursen, U ^a   Eskandari, G ^a   Kaya, T I ^a   Tamer, L ^a   Ikizoglu, G ^a   Atik, U ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Apolipoprotein E gene; Cholesterol; Lipoprotein; Polymorphism; Xanthelasma

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; LIPID BLOOD LEVEL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN METABOLISM; PROTEIN POLYMORPHISM; RANDOMIZATION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; XANTHELASMA; XANTHOMA;

APOLIPOPROTEINS A; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES; TURKEY; XANTHOMATOSIS;

EID: 33645981588     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01418.x     Document Type: Article

References (22)

1. Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum. J Am Acad Dermatol 1994; 30: 236-241.
2. Allander E, Björnsson OJ, Kolbeinsson A et al. Incidence of xanthelasma in the general population. Int J Epidemiol 1972; 1: 211.
3. Altmann J, Winkelmann RK. Diffuse normolipidemic plane xanthoma. Arch Dermatol 1962; 85: 633-640.
4. Pedace FJ, Winkelmann RK. Xanthelasma palpebrarum. JAMA 1965; 193: 121-122.
5. Mahley RW. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-630.
6. Frikke-Schmidt R. Context-dependent and invariant associations between apoE genotype and levels of lipoproteins and risk of ischemic heart disease: A review. Scand J Clin Lab Invest 2000; 60: 3-26.
7. Gomez JA, Gonzalez MJ, Moragas JM et al. Apolipoprotein E phenotypes, lipoprotein composition, and xanthelasmas. Arch Dermatol 1988; 124: 1230-1234.
8. Bergman R, Kasif Y, Aviram M et al. Normolipidemic xanthelasma palpebrarum: Lipid composition, cholesterol metabolism in monocyte-derived macrophages, and plasma lipid peroxidation. Acta Derm Venereol 1996; 76: 107-110.
9. Ribera M, Pinto X, Argimon JM et al. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma. Am J Med 1995; 99: 485-493.
10. Douste-Blazy P, Marcel YL, Cohen L, Giroux JM, Davignon J. Increased frequency of apoE-ND phenotype and hyperapobetalipoproteinemia in normolipemic subjects with xanthelasmas of eyelids. Ann Intern Med 1982; 96: 164-169.
11. Watanabe A, Yoshimura A, Wakasugi T et al. Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum. Atherosclerosis 1981; 38: 283-290.
12. Scott PJ, Winterbourn CC. Low-density lipoprotein accumulation in actively growing xanthomas. J Atheroscler Res 1967; 7: 207-223.
13. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
14. Suits SG, Chait A, Aviram M, Heinecke JW. Phagocytosis of aggregated lipoprotein by macrophages: Low-density lipoprotein receptor-dependent foam-cell formation. Proc Natl Acad Sci USA 1989; 86: 2713-2717.
15. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jurgens G. Biochemical, structural, and functional properties of oxidized lower-density lipoprotein. Chem Res Toxicol 1990; 3: 77-92.
16. Segal P, Insull W, Chambless LE et al. The association of dyslipoproteinemia with cornel arcus and xanthelasma. Circulation 1986; 73: 108-118.
17. Pinto X, Libera M, Fiol C. Dyslipoproteinemia in patients with xanthelasma. Arch Dermatol 1989; 125: 1281-1282.
18. Gomez JA, Gonzales Duarte MJ, de Moragas JM. Dyslipoproteinemia in patients with xanthelasma. Arch Dermatol 1984; 125: 1282.
19. Bates MC, Warren SG. Xanthelasma: Clinical indicator of decreased levels of high-density lipoprotein cholesterol. South Med J 1989; 82: 570-574.
20. Gomez JA, Rodrigues JM, Mora J. Composition of the lipoproteins of high density and its subfractions: Modifications in survivors of sharp heart attack of myocardium and hiperlipemia. Med Clin 1986; 87: 322-325.
21. De Backer G, Rosseneu M, Deslypere JP. Discriminative value of lipids and apoproteins in coronary heart disease. Atherosclerosis 1982; 42: 197-203.
22. Menzel HJ, Kladetzky RG, Assman G. Apolipoprotein polymorphism and coronary artery disease. Arteriosclerosis 1983; 3: 310-315.